BRIEF — Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Oct 16 (Reuters) — POLYPEPTIDE GROUP AG: Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics Co., Ltd. Samsung Peptide Holds 87.92% Of Polypeptide Share Capital 87.59% Of Polypeptide Shares Tendered Into Offer Minimum Acceptance Rate Condition Of Offer Satisfied No Material Adverse Effect Conditio